The Future of Rapid Variant Analytics, Showcasing Multi-OMICs Clinical Insights
GenomeArc webinar with Ms. Marese Grehan, GenomeArc's genomics software specialist! She will be talking about The Future of Rapid Variant Analytics, Showcasing Multi-OMICs Clinical Insights. This talk highlights the GenomeArc Horizon platform and its innovative features designed to improve diagnostic and therapeutic insights for oncology and rare diseases.
Learn more about GenomeArc Horizon Platfor: https://genomearc.com/horizon
Visit: www.genomearc.com
For Queries, Email: [email protected]
This webinaer is copy righted property of GenomeArc Inc.
GenomeArc Inc. is a biotech company on clinical genetics and drug discovery headquartered in Mississauga, Ontario. The company began its journey in 2021, GenomeArc develops artificial intelligence integrated solutions for genetic diagnosis and genomic drug development solutions for rare genetic disorders and pan cancer. As a research-oriented biotech company, GenomeArc brings new insights into rare diseases, cancer diagnosis, and therapeutics through genome analysis. The GenomeArc team is constantly innovating technologies to solve phenotypic complexities in genetic variations for rapid intervention. As a global company, our aim is to make efficient and accurate genome medicine technologies accessible for all healthcare systems.
#Genomics #CRISPR #GenomeArc #MohammedDafil #DubaiFutureFoundation #FutureOfMedicine #Biotech #PrecisionMedicine #DNA #GeneticEngineering #Innovation #Science #cancer #cancergenome #tumor #genes #genomics